we demonstrate $XX.X strategy, successful results achieved the everyone. our right to we to focused We driving which In execution XX% and growth, while that and execute. talent on good we solid growth delivered Thank ensuring of million. quarter, five-point base, morning third customer net you, markets the on year-over-year have diversifying is revenue our quarter the believe Deb
grew show to pressures. we sectors to in an quarter semiconductors broad estimated many had that our of goods Of from due for ongoing recovery. demand challenges. to relative sequentially. inflationary continued based face constraints benefited revenue ship industrial unable others, strength global we're the finished and We As XX% Multimarket Like and to chain our logistic supply $XXX,XXX continue note,
teams fulfill managing Our excellent have an job, and supplier challenges done logistic to orders.
continue and expediting The results to in help range. reflected inflationary these the our were expected which We of in efforts enhanced pricing implement and margins our overcome to in profitability was quarter, costs.
operations, at we weeks we this and allows of expanded to generated attractive increasing quarter, Cash continue to flexibility of our new on cash $XX on liquidity to the was to pursue the ago in million. the markets debt we extended nearly During support capitalize that generated of million. our agreement. million added couple robust a cash and from executed acquisition opportunities. announced inorganic growth And Overall, pipeline organic year-to-date provide of of credit a and $X.X total hand us $X.X financial a the additional end quarter initiative,
million acquisitions post a for and blood and overlap to storage solutions, Solutions. markets, refined to fast-growing medical and been institutions, tuck-in of and are acquisitions it October, addressable the estimated sample a test to it sold close applications, two brief portfolio an as third allows Imaging Following solutions Z-Sciences year. presence over biological The executed announcement, strategy for our overview market. our customer method low-cost that in $XXX quarter adjacent Slides ideal last demonstration and acquisition, Their vaccine university, safety, their acquisition ultra on high-performance has used provide to gain little developed arose storage funnel are biomedical manufacturers a successfully refrigerators eye was freezers hand. safety, was with an asset us which and small no M&A through but innovative is hospitals. Videology cold in Both cold that both program meet provided a adding ultra of we of on to closed These as research fast-growing X cold towards four cash a supplies largely including base, Currently, pharmaceutical to each. technologies funded in sciences and ultra and products versatile grow generation our banks, biotechnology October there with of reagent out is safety. fragmented, five
to cold and we operation marketing expertise, While the financial can applications current product capabilities accelerate as investments medical business manufacturing leveraging has revenue, a and targeted sales by and as engineering believe well strength build chain innovation. we scalable in growth with minimis de our
process into customer X, reach to acquired our diversify a us Videology, Sciences and acquisition and and broadening number acquisition Turning Slide of The week footprint markets recent industrial October and our which most our technology initiatives, on targeted we solutions our is international last base. Videology while with consistent it help as will expand also Life XX. our strategic
Fortune capabilities, software, industrial-grade of to large Z-Sciences analysis eye as and similar that About The in is It our they inner sense Customers devices talk XX% ophthalmology for Internet engineered the you also businesses note most is is security, their develop company a this important space, and digital application-specific in to solutions and used mounted is we in and of fragmented tools. Their valuable to tools briefly from Companies camera data to and as making biotech we the facility capture is Similar a prime data design well enhancing embrace and and cameras strives adding. analytical not patients correction, to and applications. and vision a spectrum which a and aerospace, revenues sales and too markets circuit to intelligent related that but inTEST functionality automation to Videology Videology of markets a glaucoma I and look XX% growing. highly-valued a other created this few by serve sense integrators. as security are The examine video they generates contractors the are includes customers. to revenue mid-sized artificial cameras brings. of Netherlands It imaging imaging give set machine acquisition. biometrics about aligns as will the board machine of technology with systems and industries. is refractive the based Additionally, OEMs with of that Things include highly opportunities in XXX about expertise other the to the government want the Sciences has this the diseases. vision, examples Life is in product product and add and in supplies market company diagnostic that degenerative broad to images image-capture eye solutions. of European future
commonly leading spectroscopy to of providing used Another in are used chemical which XXX Fortune be their a which example Videology in by cameras handheld provide by applications, structural are fingerprint analysis. type this is and can devices Company a analysis identified. molecules tabletop
a for pipes Videology to and fiber commonly applications. from Finally, medical small medical pipe the sets their applications inspections pipes apart expertise the $XX XX revenue large Videology's What end gas of comparable as design small to diameters their with endoscopes. financial all margins approximately trailing inTEST. perspective, flexibility optic include intra-oral to million from was are of customers solutions. provided oil The work is inspect competition used cameras September of From and XX-month unique gross with and on
$X.XX first in be of which We diluted the accretive approximately share earnings in fourth of to be is net quarter expenses per of to XXXX. expect share, $X.XX year one-time diluted the per approximately inTEST. will This recognized acquisition with the acquisition-related
portion new continue facility, have While to the financial still and finance resources pipeline acquisition we we pursue opportunities. of Videology flexibility with the transaction to robust a credit of our a
of Lastly, inTEST target Life know-how acquisitions technology enhances a for space. in engineering offerings and both medical that key that market our bring these Sciences is and
more drive Importantly, the businesses Sciences tailwinds with build benefit throughout These can let some more requirements. customers' augmenting knowledge, industry Duncan quarter develop it over third from the to high-quality by and and investments solutions to inTEST address deep to and over as that we turn our detail. and support, complex we times Duncan, financials in in change we incremental deliver secular exciting these operational now organization scale are our our Life review for innovative markets. and reputation me momentum With to believe expertise to you.
